Exploring the Relationship Between Hepatitis C Virus Infection and Prostate Cancer Risk: A National Health and Nutrition Examination Survey Analysis
- PMID: 38516498
- PMCID: PMC10955788
- DOI: 10.7759/cureus.54523
Exploring the Relationship Between Hepatitis C Virus Infection and Prostate Cancer Risk: A National Health and Nutrition Examination Survey Analysis
Abstract
Introduction Prostate cancer and hepatitis C virus (HCV) infection stand as notable worldwide health issues. Investigating the connection between HCV infection and the risk of prostate cancer remains an ongoing endeavor, complicated by contradictory findings in prior research. It is imperative to comprehend this potential relationship in order to enhance strategies for prevention and treatment. This paper seeks to delve into the association between HCV infection and prostate cancer by analyzing data from the National Health and Nutrition Examination Survey (NHANES), a comprehensive cross-section of the US population. Methods Information extracted from the NHANES dataset encompassed the period spanning from March 2017 to March 2020, with a focus on the "medical conditions" and "hepatitis" segments. Employing logistic regression analysis, we aimed to discern the connection between HCV infection and the prior occurrence of prostate cancer. This analysis was conducted while factoring in variables such as weight, hypertension, hyperlipidemia, race, educational level, and marital status to ensure the accuracy of the findings. The results of this examination yielded adjusted odds ratios (OR), coefficients of association (B), and corresponding confidence intervals (CI). Results The outcomes derived from the comprehensive multivariate logistic regression analysis, utilizing NHANES data, indicated an absence of a statistically noteworthy correlation between HCV infection and the probability of prostate cancer occurrence. While accounting for diverse variables like weight, hypertension, hyperlipidemia, race, educational level, and marital status, no substantial relationship was observed between HCV infection and the risk of prostate cancer. These results are consistent with earlier investigations that similarly struggled to establish a definitive connection between HCV infection and the incidence of prostate cancer. Conclusion Drawing from NHANES data, this study indicates the absence of a substantial link between HCV infection and the incidence of prostate cancer. The divergent findings observed in prior research accentuate the intricate nature of the connection between HCV infection and prostate cancer. Future investigations should encompass more extensive sample sizes, prospective frameworks, and a meticulous assessment of potential variables that might confound the results. Furthermore, it is important to examine the potential protective impact of HCV infection due to antiviral interventions and its effect on the associated risk of prostate cancer. Such endeavors would offer valuable insights for individuals grappling with these health challenges.
Keywords: hcv; hepatitis c; nhanes; prostate cancer; risk.
Copyright © 2024, Ganz et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Similar articles
-
The association between periodontitis and hepatitis virus infection: a cross-sectional study utilizing data from the NHANES database (2003-2018).Public Health. 2024 Jan;226:114-121. doi: 10.1016/j.puhe.2023.11.005. Epub 2023 Dec 5. Public Health. 2024. PMID: 38056398
-
Investigating the Anti-inflammatory Effect of Allopurinol on the Prevention of Prostate Cancer.Cureus. 2023 Jun 6;15(6):e40058. doi: 10.7759/cureus.40058. eCollection 2023 Jun. Cureus. 2023. PMID: 37425589 Free PMC article.
-
Sex and age differences in lipid response to chronic infection with the hepatitis C virus in the United States National Health and Nutrition Examination Surveys.J Viral Hepat. 2011 Aug;18(8):571-9. doi: 10.1111/j.1365-2893.2010.01347.x. Epub 2010 Jul 19. J Viral Hepat. 2011. PMID: 20642483
-
Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses.Adv Parasitol. 2016;91:111-231. doi: 10.1016/bs.apar.2015.12.003. Epub 2016 Feb 5. Adv Parasitol. 2016. PMID: 27015949 Review.
-
The burden of hepatitis C in the United States.Hepatology. 2002 Nov;36(5 Suppl 1):S30-4. doi: 10.1053/jhep.2002.36791. Hepatology. 2002. PMID: 12407574 Review.
References
-
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. CA Cancer J Clin. 2021;71:209–249. - PubMed
-
- World Health Organization. Hepatitis C. 2020. https://www.who.int/news-room/fact-sheets/detail/hepatitis-c https://www.who.int/news-room/fact-sheets/detail/hepatitis-c
-
- Increased cancer rates in patients with chronic hepatitis C. Nyberg AH, Sadikova E, Cheetham C, et al. Liver Int. 2020;40:685–693. - PubMed
-
- Correlation of hepatitis C and prostate cancer, inverse correlation of basal cell hyperplasia or prostatitis and epidemic syphilis of unknown duration. Krystyna A, Safi T, Briggs WM, Schwalb MD. Int Braz J Urol. 2011;37:223–229. - PubMed
LinkOut - more resources
Full Text Sources